|
Information
Section: Conditions
Condition:
OCD
Article: Treatment of
Obsessive-Compulsive Disorder Overview
Source: Leslie E. Packer,
PhD
File Last Updated: December
2004
|
Page 1 of
1
|
|
Article
Table of Contents
|
|
|
|
"MY
THOUGHTS"*
|
- They come on so
strong
- They stay for a
while
- They never leave
me alone
- I have the power
to stop them
-
- They interfere
with my daily life
- They stop me from
enjoying myself
- They keep me
isolated from my loved ones
- I have the power
to stop them
-
- They disrupt my
sleep
- They change the
person that I am
- They are my
thoughts
- I have the power
to stop them
|
|
PREFACE
|
|
When it comes to the
treatment of OCD, patients will find that unlike
some conditions where only medication seems to be
really effective, there are nonmedication
treatments for OCD that are just as -- or more --
effective than medication. In the remainder of this
article, we will summarize some of the research on
these treatments and talk a bit about what else is
available if the "first line" treatments either do
not work or the individual cannot or does not
comply with the treatment regimen.
We will also consider
the role of the family, because although family
always makes a difference, when it comes to OCD,
well-meaning family members often inadvertently
enable the problematic behavior and
patterns.
|
|
MEDICATION MANAGEMENT OVERVIEW
|
|
The class of
medications known as SSRIs (Selective Serotonin
Reuptake Inhibitors) appear to be the first-line
treatments pharmacologically. In the U.S.,
available SSRIs include fluoxetine hydrochloride
(Prozac®), paroxetine hydrochloride
(Paxil®), sertraline hydrochloride
(Zoloft®), fluvoxamine maleate1,
citalopram (Celexa®), and escitalopram oxalate
(Lexapro®), although the only ones that are
actually FDA-approved for treatment of OCD are
fluoxetine, sertraline, and
fluvoxamine.
Research on the SSRIs
suggest that they are effective in treating OCD in
adults, children, and adolescents, and that they
produce changes in the brain that may persist after
treatment is discontinued. While the symptoms of
OCD may be disabling for some, the good news is
that about 60 - 70% of OCD sufferers benefit from
treatment. Some patients report feeling some
improvement within days of starting an SSRI, but it
may take weeks before the levels build up in the
system sufficiently to give the individual any
noticeable relief. The other 30 - 40% generally do
not respond well to SSRIs or do not achieve
satisfactory results with SSRIs. Patients with OCD
who have poor insight (as to the irrationality of
their obsessions and compulsions) do not respond as
well to SSRIs as those with good insight.
Another non-SSRI
medication, clomipramine hydrochloride
(Anafranil®) is approved for treatment of OCD,
and while it has a somewhat stronger side effect
profile than the SSRIs, it appears to be more
effective than the SSRIs in treating OCD in
both adults and children. Because of its stronger
side effect profile, however, it is generally not
considered a "first line" treatment.
As suggested above,
some patients do not achieve adequate results with
medication. Others achieve some results, but
relapse when treatment is discontinued. Maina et
al. (2001) looked at what happens when someone who
relapses is put back on the SSRI that had helped
them before to investigate whether putting the
individual back on the SSRI would produce the same
benefits as it originally produced. The results
indicated that response was poorer when the SSRIs
were reinstated, regardless of type of SSRI used.
Their data suggest that if someone relapses and
goes back on the same SSRI that helped them before,
they will get some benefit, but not as much as they
got before. For that reason, the patient and
clinician need to carefully consider whether to
discontinue medication if the patient is doing well
or whether to continue the patient on a maintenance
schedule.
|
|
MEDICATIONS -
ADVERSE EFFECTS
|
|
The SSRIs do have
side effects that may be problematic in some cases.
Insomnia or somnolence, nausea, diarrhea, sweating
or tremor, activation or hypomania, and delayed
ejaculation or impotence are just some of the
adverse side effects that have been reported in the
literature. Some patients have also reported a
withdrawal-emergent effects associated with
stopping SSRIs. As with other medications, patients
taking SSRIs need to be educated about potentially
dangerous medication combinations, including
combinations with over-the-counter compounds.
The activation or
hypomania adverse effect is one that has drawn
particular attention because it raises the question
of whether the use of SSRIs in children or
teenagers might "trip" a child into Bipolar
Disorder. At the present time, available research
suggests that hypomania may be a genuine side
effect of SSRIs and that it may trigger a "switch"
in those who already have a bipolar disorder or are
vulnerable to one.
One other potential
adverse effect is something called "amotivational
syndrome," a frontal lobe syndrome associated with
the use of SSRIs that is characterized by apathy
and lack of motivation. Garland and Baerg (2001)
reported on four children and one adolescent who
experienced this syndrome while on SSRIs; one of
the children also experienced behavioral
disinhibition. The authors note that the symptoms
were dose-related and reversible, but that the lack
of insight in patients and delayed onset indicate
that clinicians need to inform patients and
families of the potential symptoms.
Use of SSRIs in
children with OCD has recently been called into
question by other research on suicidality related
to the use of SSRIs in treating major depression in
children. In 2004, the UK and US both issued
statements stating that SSRIs should not be
prescribed for children with Major Depressive
Disorder and the safety issues continue to be
debated in the professional literature. Since many
children and teens with OCD also have depression,
parents need to have a serious discussion with
their child's prescribing physician about any risks
that might exist in prescribing SSRIs for OCD in
the presence of a history of depression or current
depressive symptoms.
If you're not sot
sure what to ask your doctor when medications are
being considered for any of the conditions
discussed on this web site, see my suggestions in
"Questions
to Ask About Medications."
|
|
SURGERY
FOR OCD
|
|
Surgery may also be
an option for some people with severe
treatment-resistant OCD. The topic is too complex
to discuss on a web site of this type, but there
are some data suggesting that in severe OCD that
has not responded to medication and therapy,
certain surgical procedures may be of benefit.
|
|
SUPPLEMENTS AS ALTERNATIVE TREATMENT
FOR OCD
|
|
A number of
alternative treatments involving supplements or
other approaches have had some anecdotal support
for effectiveness, but to date, none have really
demonstrated significant effectiveness in
controlled experiments. If you are considering
alternative approaches, you can research them on
the alternative
treatment databases
and resources listed elsewhere on this site. I did
receive email from a site visitor urging me to
mention the use of Inositol as a complementary or
alternative treatment. Unfortunately, in my zeal to
protect site visitor confidentiality, I deleted his
correspondence and I don't have it available to go
back to now, other than my recollection that he
reported that Inositol was of significant benefit
to him above and beyond any prescribed OCD
medications. As with all complementary supplements,
it is important to note that they often lack
controlled research demonstrating their efficacy
over and above any placebo effects, but it doesn't
mean that it might not help any one individual.
Inositol is a good example of this, as some
preliminary research had suggested it might be
effective, but further research did not really
demonstrate any significant benefit over and above
placebo when both were added to an
SSRI treatment program. The use of Inositol
has somewhat stronger support for its use in Panic
Disorder, but for OCD itself, there isn't a lot of
compelling research to suggest it should be a
first-line treatment. The March 2006
Supplement
Watch
newsletter is an interesting discussion and
commentary on the state of research on supplements
that site visitors may wish to read.
|
|
COGNITIVE BEHAVIOR THERAPY OVERVIEW
|
|
One of the most
clinically effective approaches to treating OCD is
a nonmedication approach, Cognitive Behavior
Therapy (CBT). The term "CBT" refers to a broad
class of therapeutic interventions that involve
changing both the individual's cognitions
(thoughts) and behavior. Of particular relevance is
the type of CBT known as Exposure-Response
Prevention therapy (ERP). In ERP, the client and
therapist may construct a hierarchy of situations
that are progressively more difficult in terms of
resisting the need to engage in the targeted
compulsive behavior. The client is taught how to
relax, and then starting with the least intense
item on the hierarchy, the client intentionally
exposes him/herself to the 'trigger' for the
compulsive behavior while resisting the performance
of the behavior itself.
The "exposure" can be
done in the patient's imagination and/or in "real
life." The logic of the technique is fairly
straightforward. In the presence of the 'trigger'
or the obsessive thought, the individual's anxiety
will rise. Prior to therapy, the individual would
engage in the compulsive ritual and thereby reduce
the anxiety. The problem with that, however, is
that the performance of the ritual was actually
reinforced ("rewarded") by reduction in anxiety,
thereby strengthening the likelihood that
the individual will engage in the compulsive
behavior again in the presence of the
anxiety-producing obsessive thought.
In ERP, the trigger
is present and the individual's anxiety is
generated, but now the compulsive behavior is not
performed. What will happen? The first thing that
happens is that anxiety levels will probably rise.
And rise. And rise. If the individual is able to
employ any relaxation or distraction techniques and
is able to successfully stop herself from
performing the ritual/compulsive behavior,
eventually (and "naturally"), the anxiety will
start to subside. This part of the process is known
as "extinction" -- the anxiety response is not
followed by any consequences, and so extinguishes
or dies out. The next time the individual is
exposed to the trigger/stimulus, their anxiety will
rise again, but again, if they don't perform the
compulsive behavior, their anxiety will extinguish.
Over sessions and weeks, the individual's anxiety
will diminish to a point where the trigger/stimulus
no longer produces an anxiety response. At that
point, the therapist and client may go to a more
challenging item from the hierarchy.
Participating in CBT
is hard work. Young children often lack insight
into the irrationality of their obsessive thoughts
and/or may not be motivated to address what the
adults in their lives see as a significant problem.
And even adults who do have insight may find the
anxiety so overwhelming that they are unable to
even get started in such therapy. For those who
have very severe OCD, a combination of medication
and therapy may be indicated, with the medication
serving to bring the OCD symptoms down to a
manageable level so that the individual can benefit
from the therapy, but even that is controversial,
because if you reduce the person's symptoms via
medication, you may also reduce their motivation to
do the cognitive-behavioral work.
Piacentini and his
colleagues at UCLA conducted open trials on CBT
with children with OCD (2002). The 42 children
(approximately half of whom were on medication at
baseline) were given a treatment protocol based on
ERP. For the sample, there was a clinically
significant response to treatment. The
investigators note that for this sample, poorer
outcome was associated with more severe obsessions
and greater OCD-related academic impairment prior
to treatment.
There are many
variations on CBT and the preceding was meant
simply to give you an idea of the kind of approach
that might be used. A number of intriguing research
reports have appeared in the literature, with some
investigators comparing in vivo exposure to the
'trigger' to purely cognitive strategies. Some
investigators have suggested that cognitive therapy
alone (without the actual exposure) may be as
effective as ERP.
|
|
COMBINING MEDICATION AND PSYCHOTHERAPY
|
|
A recent report by
Dr. John March and his colleagues (October, 2004
JAMA) directly investigated whether CBT alone, SSRI
medication alone, or CBT and SSRI therapy combined
were most effective in treating OCD in children and
adolescents. In their multi-center study,
sertraline was the SSRI used for the SSRI
condition. The SSRI-alone, CBT-alone, and SSRI-CBT
combination were all significantly more effective
than the placebo condition. Additional analyses of
their data suggested that children and teens with
OCD should begin treatment with a combination of
CBT plus an SSRI or just start with CBT
alone.
|
|
ROLE OF THE FAMILY
|
|
Regardless of whether
OCD is inherited or nonfamilial, it impacts the
entire family. Parents or family members are often
at a loss as to whether to accommodate the
relative's symptoms and possibly enable them, or
"hang tough" or take some other course.
Amir et al. (2000)
looked at: (1) the family's reactions to OCD as a
function of the severity of the patient's symptoms
and (2) the effects of family accommodation and
rejection on treatment outcome. Their results
indicated that family distress, accommodation, and
rejection were related to depression and anxiety
in the family members, but not to severity
of the patients' OCD. At post treatment, family
accommodation was related to the severity of
patients' OCD, i.e., if the family "made
allowances" or "accommodations," the patient was
more likely to have more severe symptoms. Thus,
family factors can predispose a child to OCD,
maintain the symptoms, or actually enable them.
Getting the family involved in treatment is
obviously an important component in planning any
treatment regimen. Training the family how to
respond to the child or family member, and
interventions oriented towards training family
members to use techniques that foster
problem-solving, independence, and greater
self-confidence may all improve the child's
functioning.
|
|
NOTE
|
|
"My Thoughts,"
©
2001, Loren Packer-Hopke. All rights
reserved.
|
|
Information
Section: Conditions
Condition:
OCD
Article: Treatment of
Obsessive-Compulsive Disorder Overview
Source: Leslie E. Packer,
PhD
File Last Updated: December
2004
|
Page 1 of
1
|
|
Tourette
Syndrome "Plus" © Copyright 1998 - 2006 Leslie
E. Packer, PhD. except as noted.
All rights reserved
This page last updated April 7, 2006.
Reprint
Policy.
Privacy
Policy.
Contact.
|
|